Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2023 | Open-labeled, multicenter phase II study of prophylactic administration of pegylated granulocyte colony-stimulating factor in relapsed or refractory multiple myeloma who received pomalidomide-based regimens (KMM170) | FRONTIERS IN ONCOLOGY |